# scRNAseq-analysis-or-resectable-esophageal-squamous-cell-carcinoma
Multi-omics analyses found the expansion of TRGC2+NKT cells in peripheral blood was significantly correlated with neoadjuvant treatment effectiveness. These findings showed preoperative pembrolizumab plus chemotherapy could be a promising therapeutic strategy for resectable ESCC.
